Cargando…

Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial

BACKGROUND: Type 2 circulating vaccine-derived polioviruses (cVDPV2) from Sabin oral poliovirus vaccines (OPVs) are the leading cause of poliomyelitis. A novel type 2 OPV (nOPV2) has been developed to be more genetically stable with similar tolerability and immunogenicity to that of Sabin type 2 vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaman, Khaelqu, Bandyopadhyay, Ananda S, Hoque, Masuma, Gast, Christopher, Yunus, Mohammad, Jamil, Khondoker M, Mainou, Bernardo A, Konopka-Anstadt, Jennifer L, Hendley, William S, Vincent, Annelet, Clemens, Ralf, Clemens, Sue Ann Costa, Ross, Allen G, Clemens, John D, Tritama, Erman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860215/ https://www.ncbi.nlm.nih.gov/pubmed/36495882 http://dx.doi.org/10.1016/S0140-6736(22)02397-2

Ejemplares similares

Improvement of the qmosRT-PCR Assay and Its Application for the Detection and Quantitation of the Three Serotypes of the Novel Oral Polio Vaccine in Stool Samples
por: Manukyan, Hasmik, et al.
Publicado: (2023)

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
por: Wahid, Rahnuma, et al.
Publicado: (2021)

Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame
por: Gaensbauer, James T, et al.
Publicado: (2018)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials
por: Wahid, Rahnuma, et al.
Publicado: (2022)

Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2017)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2021)

Safeguarding vaccine production and supply strategies for polio eradication endgame
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2021)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
por: Sáez-Llorens, Xavier, et al.
Publicado: (2021)

Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children
por: Wahid, Rahnuma, et al.
Publicado: (2022)

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study
por: Taniuchi, Mami, et al.
Publicado: (2017)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
por: De Coster, Ilse, et al.
Publicado: (2021)

Rotavirus Vaccine Trials in International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and Future Use of the Vaccine in Bangladesh
por: Zaman, K, et al.
Publicado: (2021)

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study
por: Van Damme, Pierre, et al.
Publicado: (2019)

Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America
por: Lopez-Medina, Eduardo, et al.
Publicado: (2017)

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2021)

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience()
por: Macklin, Grace R., et al.
Publicado: (2023)

Shedding light on dark matter – faecal microbiota transplantation in Europe
por: Wortelboer, Koen, et al.
Publicado: (2021)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Faecal shedding of SARS-CoV-2: considerations for hospital settings
por: Patel, J.
Publicado: (2020)

Herd protection of unvaccinated adults by oral cholera vaccines in rural Bangladesh
por: Ali, Mohammad, et al.
Publicado: (2019)

Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
por: Yeh, Ming Te, et al.
Publicado: (2020)

Faecal shedding, alimentary clearance and intestinal spread of prions in hamsters fed with scrapie
por: Krüger, Dominique, et al.
Publicado: (2009)

Cold-Chain Adaptability During Introduction of Inactivated Polio Vaccine in Bangladesh, 2015
por: Billah, Mallick M., et al.
Publicado: (2017)

Time Taken to Detect and Respond to Polio Outbreaks in Africa and the Potential Impact of Direct Molecular Detection and Nanopore Sequencing
por: Shaw, Alexander G, et al.
Publicado: (2021)

Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage
por: Altamirano, Jonathan, et al.
Publicado: (2018)

Acute Polio-Encephalitis and Polio-Myelitis
Publicado: (1905)

Faecal shedding and strain diversity of Listeria monocytogenes in healthy ruminants and swine in Northern Spain
por: Esteban, Jon I, et al.
Publicado: (2009)

Dynamics of faecal shedding of ESBL- or AmpC-producing Escherichia coli on dairy farms
por: Hordijk, Joost, et al.
Publicado: (2019)

Oral Mutian®X stopped faecal feline coronavirus shedding by naturally infected cats
por: Addie, Diane D., et al.
Publicado: (2020)

Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative
por: Thompson, Kimberly M., et al.
Publicado: (2022)

Polio
por: Gould, Tony
Publicado: (1999)

Polio
por: Viswanathan, R.
Publicado: (1949)

Polio
por: Pucchio, Aoife M.R., et al.
Publicado: (2022)

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Faecal shedding of rotavirus vaccine in Chinese children after vaccination with Lanzhou lamb rotavirus vaccine
por: Li, Jin-song, et al.
Publicado: (2018)

Association between faecal shedding of feline coronavirus and serum α1-acid glycoprotein sialylation
por: Paltrinieri, Saverio, et al.
Publicado: (2008)

1668. No Impact of Nutritional Status on Oral Polio Vaccine shedding after Vaccination of Under 5 Children in Rural Mexico
por: Nino-Tapias, Gianna J, et al.
Publicado: (2019)

The Challenge of Polio
por: Horstmann, Dorothy M.
Publicado: (1947)

Cannot write session to /tmp/vufind_sessions/sess_dn4g5i6uu7rdvtgf97qt6j25pt